Alto Neuroscience, Inc. (ANRO)

SEC filing

Alto Neuroscience, Inc.

ANRO · CIK 1999480

4 · Oct 1, 2026 · PRESIDENT AND CFO Smith Nicholas Conrad sold 134.89K shares at $26.45/share ($3.6M); exercised options for 269.77K shares

PRESIDENT AND CFO Smith Nicholas Conrad sold 134.89K shares at $26.45/share ($3.6M); exercised options for 269.77K shares

FORM 4

xslF345X06/wk-form4_1790904813.xmlSEC.gov

Graphics and non-inline formats (not embedded below).